Mark L. Perry
Mr. Perry has served as a member of GBT’s board of directors since April 2015. He has extensive experience serving in professional and management positions in the biotechnology industry. Previously, he served as an entrepreneur-in-residence at Third Rock Ventures, a venture capital firm. Previously, he was president and chief executive officer of Aerovance. Prior to that, he served as the senior business advisor for Gilead Sciences following his tenure as an executive officer for such company, during which time he served in a variety of capacities including general counsel, chief financial officer and executive vice president of operations. Earlier in his career, he served as an attorney and partner at Cooley LLP. Mr. Perry currently serves on the board of directors of NVIDIA and previously served on the board of directors at MyoKardia. He received a B.A. in history from the University of California, Berkeley, and a J.D. from the University of California, Davis.